Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD) Valuation In Focus As Sector Interest Lifts Premium Royalty And Streaming Stocks

Why Royal Gold’s Premium Valuation Is Back in Focus The recent sector wide interest in gold focused stocks has pushed Royal Gold (RGLD) firmly into the spotlight, as its premium valuation relative to its historical fair value raises fresh questions for investors. See our latest analysis for Royal Gold. Royal Gold’s share price has moved sharply over recent months, with a 1 day share price return of 4.79%, a 30 day share price return of 8.39%, and a 90 day share price return of 43.87%. Its 1...
NYSE:RBLX
NYSE:RBLXEntertainment

Will Roblox’s Soaring Sales And Losses Reshape The Growth Story For Roblox (RBLX)?

In early February 2026, Roblox reported fourth-quarter 2025 results showing sales rising to US$1.42 billion from US$988.18 million a year earlier, while net loss widened to US$316 million from US$219.57 million. Beyond the headline numbers, the company highlighted sharp growth in bookings, daily active users, and engagement hours, underpinned by expanded safety measures such as facial age verification and a growing adult user base. With recent share gains and accelerating user engagement,...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

ACI Worldwide Extends Retail Reach With Alpha Modus Remittance Partnership

ACI Worldwide (NasdaqGS:ACIW) has entered a multi year partnership with Alpha Modus Financial Services. The agreement focuses on powering remittance and bill payment services across convenience, grocery, and community retail locations. The deal aims to extend ACI Worldwide's payment technology into more physical retail environments that serve cash and hybrid payment users. ACI Worldwide, trading at $42.28, sits at the intersection of digital and in store payments, and this partnership adds...
NYSE:WTM
NYSE:WTMInsurance

Why White Mountains Insurance Group (WTM) Is Up 6.8% After Surging Q4 Profitability And EPS Turnaround

White Mountains Insurance Group reported fourth-quarter 2025 revenue of US$1,603.8 million and net income of US$835.8 million, reversing a year-earlier loss and lifting earnings per share from a loss of US$50.78 to profit of US$327.23. For the full year 2025, revenue rose to US$3.74 billion and net income to US$1.11 billion, with earnings per share from continuing operations increasing from US$89.79 to US$430.14, highlighting a very large improvement in profitability. We’ll now examine how...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Rumble (RUM) Valuation Check As Rumble Shorts Launch Targets Higher Engagement And Monetization

Rumble Shorts launch and why it matters for Rumble stock Rumble (RUM) has launched Rumble Shorts, a short form vertical video feed on the web, with mobile rollout pending app store approvals. This gives investors a fresh product to consider. The new format lets users swipe through videos of 90 seconds or less, tip creators through Rumble Wallet, and discover channels more easily. These features could influence how investors evaluate engagement and monetization potential. See our latest...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Is Coinbase (COIN) Turning Security Intelligence Into Its Core Competitive Edge In Crypto Infrastructure?

In late January 2026, Crypto ISAC and Coinbase announced an expanded integration that enables continuous, high-confidence sharing of Coinbase-sourced threat intelligence with the Crypto ISAC member community to help identify, disrupt, and mitigate sophisticated crypto-related attacks without exposing Coinbase customer data. This move highlights how Coinbase is positioning itself as a security-focused infrastructure partner, using automated, standards-based intelligence sharing to bolster...
NasdaqGS:GT
NasdaqGS:GTAuto Components

Is It Time To Reassess Goodyear Tire & Rubber (GT) After Its Recent Share Price Rise?

If you are wondering whether Goodyear Tire & Rubber's current share price reflects its true worth, you are not alone. Many investors are asking if the recent moves are justified by underlying value. The stock last closed at US$10.54, with returns of 12.0% over 7 days, 14.2% over 30 days, 18.2% year to date and 25.5% over the past year, while the 3 year and 5 year returns stand at a 2.9% decline and a 25.1% decline respectively. Recent price action has put a spotlight on how the market...
NYSE:WST
NYSE:WSTLife Sciences

Is It Time To Revisit West Pharmaceutical Services (WST) After Recent Share Price Rebound?

If you are wondering whether West Pharmaceutical Services is fairly priced or offering value right now, looking at a clear, structured view of its valuation can help you decide how it fits into your watchlist. The share price closed at US$248.95, with a 7.7% gain over the last 7 days, while the 1 year return sits at a 22.3% decline and the year to date return is a 9.9% decline. Over the past month, the stock recorded a 9.6% decline, and over 3 and 5 year periods the returns are 7.4% and...
NYSE:UTZ
NYSE:UTZFood

Is Utz Brands (UTZ) Pricing Look Attractive After Multi‑Year Share Price Decline

If you are wondering whether Utz Brands at around US$10.98 is a bargain or fairly priced, this article will walk you through what the current share price might be implying. The stock has posted a 4.2% return over the last week and 10.5% over the last month, although it still shows a 6.7% return year to date and a 16.2% decline over the last year, extending to a 29.1% decline over three years and 53.6% over five years. Recent coverage of Utz Brands has focused on the company as a listed snack...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) Valuation Check After Record Results And Strong AI Test Demand Guidance

FormFactor (FORM) has drawn fresh attention after releasing record fourth quarter and full year 2025 results, with earnings and revenue ahead of expectations and guidance that points to meaningfully higher first quarter 2026 revenue. See our latest analysis for FormFactor. The earnings beat and upbeat guidance appear to have reset expectations, with FormFactor’s 1 day share price return of 7.65% and 90 day share price return of 68.61% pointing to strong momentum. The 1 year total shareholder...
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

First Financial Bancorp (FFBC) Is Up 7.5% After Record Fee Income And Shelf Offering News – Has The Bull Case Changed?

First Financial Bancorp. recently reported its fourth quarter and full-year 2025 results, showing higher net interest income year on year and full-year net income of US$255.61 million, while also affirming a US$0.25 quarterly dividend and reducing net charge-offs compared with the prior year period. Alongside these results, the bank filed a US$79.29 million shelf registration for 2,753,094 common shares and continued integrating the Westfield acquisition, which boosted deposits and fee...
NYSE:TWO
NYSE:TWOMortgage REITs

Should Two Harbors Investment’s (TWO) 2025 Earnings Swing From Profit to Loss Require Investor Action?

Two Harbors Investment Corp. recently reported its fourth-quarter and full-year 2025 results, swinging from net income of US$276.73 million in the prior-year quarter to net income of US$11.72 million, and from full-year net income of US$298.17 million to a net loss of US$454.3 million. This reversal also showed up at the per-share level, with earnings from continuing operations turning into basic and diluted losses of US$0.02 for the quarter and US$4.88 for the year, highlighting a sharp...
XTRA:SRT3
XTRA:SRT3Life Sciences

Sartorius Q4 Margin Miss Shifts Focus To Earnings Quality And Mix

Sartorius (XTRA:SRT3) reported Q4 results that missed expectations, with pressure on margins. Management issued cautious guidance, highlighting a focus on margin recovery. The company plans to prioritize higher value product rollouts as part of its response. These updates signal a potential inflection point in how Sartorius balances growth, profitability, and product mix. Sartorius, a supplier of equipment and solutions for the biopharma and life sciences industry, operates within long term...
NYSE:ABR
NYSE:ABRMortgage REITs

Is Arbor Realty Trust (ABR) Pricing Reflect Long-Term Value After Steep Multi-Year Share Price Slide

If you are wondering whether Arbor Realty Trust is priced attractively right now, this article will walk you through what the current share price might be implying about its value. The stock last closed at US$7.80, with returns of 1.3% over the past week, a 3.3% decline over the past month, a 1.9% decline year to date, and a 35.9% decline over the past year, as well as a 23.3% decline over three years and a 13.0% decline over five years. Recent coverage of Arbor Realty Trust has focused on...
SWX:GIVN
SWX:GIVNChemicals

Givaudan (SWX:GIVN) Valuation Check After Full Year Results And Dividend Announcement

Why Givaudan’s latest earnings and dividend matter for shareholders Givaudan (SWX:GIVN) has put fresh numbers on the table, pairing its full year 2025 earnings release with an annual dividend announcement that gives investors clearer insight into both cash returns and recent business performance. See our latest analysis for Givaudan. The latest earnings and dividend announcement comes after a mixed share price stretch, with a 7 day share price return of 3.58% but a 1 year total shareholder...
NYSEAM:TMP
NYSEAM:TMPBanks

Why Tompkins Financial (TMP) Is Up 5.3% After Stronger 2025 Earnings And Dividend Increase

Tompkins Financial Corporation reported past fourth-quarter and full-year 2025 results showing higher net interest income and net income versus 2024, with basic earnings per share from continuing operations rising to US$6.74 for the quarter and US$11.30 for the year. Alongside these stronger earnings, the company raised its regular quarterly dividend to US$0.67 per share and completed a small share repurchase program, highlighting a continued focus on returning cash to shareholders despite...
SWX:VONN
SWX:VONNCapital Markets

Vontobel Holding (SWX:VONN) Margin Improvement To 19.6% Tests Long Term Bearish Earnings Narrative

Vontobel Holding (SWX:VONN) closed FY 2025 with second half revenue of CHF 741.7 million and basic EPS of CHF 2.94, while trailing 12 month revenue came in at CHF 1.43 billion with basic EPS of CHF 4.99, setting a clear benchmark for the latest reporting stretch. The company has seen revenue move from CHF 694.3 million and basic EPS of CHF 2.44 in 2024’s second half to CHF 741.7 million and CHF 2.94 respectively in 2025’s second half, with trailing net income of CHF 280.1 million framing a...
NYSE:LLY
NYSE:LLYPharmaceuticals

Is Eli Lilly (LLY) Still Attractive After Strong Multi‑Year Share Price Gains?

If you are wondering whether Eli Lilly's current share price still makes sense for new money, the key question is how that price lines up against its underlying value. The stock most recently closed at US$1,058.18, with returns of 2.0% over the last 7 days, a 0.5% decline over 30 days, a 2.1% decline year to date, 21.4% over 1 year, 214.0% over 3 years and a very large gain over 5 years. Recent news coverage around Eli Lilly has largely focused on its position in major treatment areas and...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Is It Too Late To Consider SanDisk (SNDK) After Its Recent Share Price Surge?

If you are wondering whether Sandisk is still worth your attention at current levels, this article will walk through what the recent share price means for its underlying value. Sandisk last closed at US$597.95, after returns of 3.8% over 7 days, 58.4% over 30 days and a very large year to date gain of 117.2%. This naturally raises questions about how the current price lines up with fundamentals. Recent coverage around Sandisk has focused on its role in the broader technology sector and how...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Pharmaceuticals (IONS) Valuation Check As Dawnzera Approval And Other Milestones Support Growth Prospects

Ionis Pharmaceuticals (IONS) is in focus after a series of drug pipeline milestones, including European Commission approval of Dawnzera, FDA Breakthrough Therapy status for zilganersen, and positive Phase 3 data for bepirovirsen from partner GSK. See our latest analysis for Ionis Pharmaceuticals. The series of regulatory wins and positive trial updates appears to be supporting momentum in Ionis Pharmaceuticals, with a 24.39% 90 day share price return and a very large 1 year total shareholder...
TSX:RIO
TSX:RIOMetals and Mining

Should Fenix Gold’s First Pour and On‑Budget Build Require Action From Rio2 (TSX:RIO) Investors?

Rio2 Limited reported that the first official gold pour at its 100% owned Fenix Gold Mine in Chile occurred on January 23, 2026, following the on-time and on-budget completion of critical construction items. This milestone marks the transition of Fenix Gold from construction to early production, potentially reshaping how investors view the company’s project execution and growth plans. Next, we’ll examine how the successful first gold pour at Fenix Gold influences Rio2’s broader investment...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Is It Time To Reassess Arm Holdings (ARM) After Its Recent Share Price Jump?

If you are wondering whether Arm Holdings' recent share price puts it at a fair level or not, this article will walk through what that current price might mean for value focused investors. The stock recently closed at US$123.70, with returns of 17.4% over the last 7 days and 10.7% over the last 30 days, while the 1 year return sits at a 23.9% decline and the year to date return is 7.8%. Recent news flow around Arm has centered on its position in semiconductor design, licensing and ecosystem...
NYSE:CW
NYSE:CWAerospace & Defense

Has Curtiss-Wright (CW) Risen Too Far After Its Strong Multi‑Year Share Price Run?

If you are looking at Curtiss-Wright and wondering whether the current share price gives you good value, this article will walk you through what the numbers are actually saying. The stock last closed at US$649.32, with returns of 7.3% over the past 30 days, 13.4% year to date, 83.3% over 1 year and a very large gain over 5 years that is just under 5x. Recent interest in Curtiss-Wright has been shaped by ongoing attention on companies in capital goods and defense related markets, as investors...
NasdaqCM:NAGE
NasdaqCM:NAGEPersonal Products

Does Niagen Bioscience (NAGE) Still Hold a Defensible NAD+ Moat Ahead of Its 2025 Earnings Call?

Niagen Bioscience, Inc. (NASDAQ: NAGE) previously announced it will report fourth quarter and fiscal 2025 results and host an investor conference call on March 4, 2026, including a general business update following the release of its earnings after market close. The company’s position as a leading NAD+ player, with FDA-recognized Niagen® and defended patents around nicotinamide riboside, highlights a reinforced regulatory moat and product pipeline momentum. We’ll now examine how the upcoming...